Reducing dose requirement of BMP-2 for osseous regeneration by microgeometry-indu
Reducing dose requirement of BMP-2 for osseous regeneration by microgeometry-indu
批准号:
8626709
负责人:
MOHAMED N RAHAMAN
金额:
$36.54万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-06 至 2017-09-30
关键词:
Alkaline PhosphataseAllograftingAreaAutologousAutologous TransplantationBiocompatible MaterialsBiological AssayBiomedical ResearchBone Morphogenetic ProteinsBone RegenerationBone ResorptionBone SubstitutesBone TransplantationCalvariaCleaved cellCleft PalateClinicalCollaborationsDefectDoseEnzyme-Linked Immunosorbent AssayFacultyFloorGenesGoldGrowth FactorHealedHeatingHistologicHydroxyapatitesImmune responseIn VitroInferiorInstitutesLaboratoriesMaxillaMaxillary SinusMesenchymal Stem CellsMicrospheresModelingMorbidity - disease rateNatural regenerationOperative Surgical ProceduresOrthopedicsOsteogenesisOutcomePatientsPhasePhysiologicalPilot ProjectsProceduresPropertyPublishingRattusReportingResearchResearch ActivitySeriesSiteStructureStudentsSurfaceTestingTrainingTraumaWorkalveolar bonebonebone morphogenetic protein 2clinical applicationclinically significantcostcost effectivecraniofacialhealingimprovedin vivonovelosteogenicphysical conditioningprogramspublic health relevancescaffoldsuccess
中文摘要
摘要
牙周病和颅面手术经常需要骨再生时,患者患有
严重吸收的牙槽骨和较差的上颌底、颅面创伤或先天性腭裂。
目前的治疗依赖于骨诱导自体移植物和同种异体移植物,以诱导临床显著的骨
而骨传导性骨替代物不能。然而,自体移植物受到可用性的限制
第二种发病率和同种异体移植物受到较差和不可预测的愈合结果的限制。成骨
骨形态发生蛋白(如BMP-2)是有效的骨诱导剂,因此它们对于
牙周和颅面骨再生。然而,传统上BMP仅在以下情况下有效:
超生理剂量,这可能导致严重的并发症和高手术成本。减量
迫切需要其更安全和具有成本效益的临床使用。我们假设一种新的内在的
骨诱导性生物材料在作为骨传导材料的同时,可以降低BMP-2的剂量需求
脚手架我们提出一种补偿或协同效应可能会显著促进骨形成,
BMP-2的剂量需求将随着内源性BMP-2水平的增加而降低。
骨诱导能力这种综合办法尚未得到报告。一种新型微凹
将为研究开发羟基磷灰石半球(McHA)。为了验证我们的假设,我们建议(1)
开发具有可控微球尺寸和降解速率的高质量McHAs,
(2)体外检测McHAs的类骨诱导活性;(3)体外评价McHAs的类骨诱导活性
McHAs对BMP-2剂量需求的影响(4)体内评价McHAs对剂量需求的影响
BMP-2的要求。该项目的成功将产生一种新型的临床安全,
骨移植替代物,可以大大促进牙周和颅面手术中的骨再生。
此外,研究活动将大大丰富和加强生物医学研究举措,
我们的研究所,通过促进新的研究主题,促进部门,教师和
实验室,并在我们的生物医学相关计划的培训学生。
英文摘要
Abstract
Periodontal and craniofacial surgeries frequently require bone regeneration when patients suffer from
severely resorbed alveolar bone and poor maxillary floor, craniofacial trauma, or congenital cleft palate.
Current treatments rely on osteoinductive autografts and allografts to induce clinically significant bone
regeneration whereas osteoconductive bone substitutes cannot. However, autografts are limited by availability
and second morbidity and allografts are limited by inferior and unpredictable healing outcomes. Osteogenic
bone morphogenetic proteins (such as BMP-2) are potent bone inducer therefore they are very attractive for
periodontal and craniofacial bone regeneration. However, traditionally BMPs are only effective at
supraphysiological doses which can induce significant complications and high surgery cost. Reducing dose
requirement is urgently needed for their safer and cost-effective clinical use. We hypothesize a new intrinsically
osteoinductive biomaterial can reduce the dose requirement of BMP-2 while serve as an osteoconductive
scaffold. We propose a compensating or synergistic effect may significantly promote bone formation because
of the combination, and the BMP-2 dose requirement will decrease with the increase of the level of the intrinsic
osteoinductive ability. Such a combined approach has not been reported yet. A novel micro-concave
hydroxyapatite hemispheres (McHAs) will be developed for the study. To test our hypothesis, we propose to (1)
Develop high-quality McHAs with controlled micro-concavity size and degradation rate that can induce varied
osteoinductive-like ability; (2) In vitro examine the osteoinductive-like property of McHAs; (3) In vitro evaluate
the effect of McHAs on dose requirement of BMP-2 (4) In vivo evaluate the effect of McHAs on dose
requirement of BMP-2. The success of the project will generate a new type of clinically safer, cost-effective
bone graft substitute that can greatly improve osseous regeneration in periodontal and craniofacial surgeries.
In addition, the research activity will significantly enrich and strengthen the biomedical research initiatives at
our institute, by prompting new research themes, promoting collaboration among departments, faculty and
laboratories, and training students in our biomedical related programs.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s10853-017-0777-3
发表时间:
2017-08
期刊:
Journal of materials science
影响因子:
4.5
作者:
[Xiao W, Zaeem MA, Li G, Bal BS, Rahaman MN]
通讯作者:
Rahaman MN
DOI:
10.1016/j.msec.2015.11.039
发表时间:
2016-03
期刊:
Materials science & engineering. C, Materials for biological applications
影响因子:
--
作者:
[Xiao W, Sonny Bal B, Rahaman MN]
通讯作者:
Rahaman MN
DOI:
10.1002/jbm.a.36897
发表时间:
2020-05
期刊:
Journal of biomedical materials research. Part A
影响因子:
--
作者:
[Injamuri S, Rahaman MN, Shen Y, Huang YW]
通讯作者:
Huang YW
Periodontal Engineering by Growth Factor Release from Hollow HA Microspheres
-
批准号:7515163
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2008
-
负责人:MOHAMED N RAHAMAN
-
依托单位:
海外基金